For instance, phosphorylation of SMADs is a critical event triggered by TGF-β signaling, and PRMT5 can methylate SMAD4 at the R361 site, increasing TGF-β pathway activity and promoting EMT and CRC metastasis [6, 50]. This evidence concerns the gene PRMT5 and colorectal carcinoma.